1-4 of 4
Daniela Sia, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Marco Ruella, MD, Rosalba Miceli, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Silvia Locatelli, PhD, Arianna Giacomini, PhD, Michele Magni, MD, Paola Matteucci, MD, Stefano Buttiglieri, PhD, Alessandra Risso, PhD, Luigi Mariani, MD, Roberto Passera, PhD, Massimo Di Nicola, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 1289.
https://doi.org/10.1182/blood.V116.21.1289.1289
Published: 2010
Journal Articles

Ph-Negative Hematopoiesis Emerging After Successful Treatment of Chronic Myeloid Leukemia Displays Severe and Persistent Telomeric Loss Which Is Particularly Prominent in Patients with Acquired Cytogenetic Abnormalities.

Chiara Lobetti Bodoni, MD, Dario Ferrero, MD, Elisa Genuardi, PhD, Daniela Sia, PhD, Mariella Genuardi, MD, Valentina Giai, MD, Alberto Rocci, MD, Luigia Monitillo, PhD, Daniela Drandi, PhD, Simone Ferrero, MD, Gianluca Isaia, MD, Elisa Bernocco, MD, Michela Boi, PhD, Monia Lunghi, MD, Elisabetta Abruzzese, MD, Massimo Pini, MD, Franca Radaelli, MD, Patrizia Pregno, MD, Roberto Passera, PhD, Gianluca Gaidano, MD, Mario Boccadoro, MD, Carmelo Carlo-Stella, MD, Marco Ladetto, MD
Journal: Blood
Blood (2009) 114 (22): 2164.
https://doi.org/10.1182/blood.V114.22.2164.2164
Published: 2009
Journal Articles

Monitoring of Post-Transplant Hematopoiesis in Patients Receiving High-Dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) with Autograft: Lack of Detection of Remarkable Abnormalities.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Alberto Rocci, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Adele Testi, PhD, Michele Magni, MD, Massimo Di Nicola, MD, Paola Matteucci, MD, Alessandra Risso, PhD, Marco Ruella, MD, Corrado Tarella, MD, Alesandro M. Gianni, MD
Journal: Blood
Blood (2008) 112 (11): 2158.
https://doi.org/10.1182/blood.V112.11.2158.2158
Published: 2008
Journal Articles

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

Carmelo Carlo-Stella, MD, Cristiana Lavazza, PhD, Arianna Giacomini, PhD, Loredana Cleris, Daniela Sia, PhD, Paolo Longoni, Marco Milanesi, Michele Magni, MD, Massimo Di Nicola, MD, Annunziata Gloghini, PhD, Antonino Carbone, MD, Marco Righi, MD, Franca Formelli, PhD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2008) 112 (11): 2605.
https://doi.org/10.1182/blood.V112.11.2605.2605
Published: 2008